Award
NIH Reporter #5R00CA267560-05
Radiation dosimetry for alpha-particle radiopharmaceutical therapy and application to pediatric neuroblastoma
Recipient
Massachusetts General Hospital, Boston, MA, USA
Award Amount
$248,997.00
Ceiling
$248,997.00
Awarded
September 03, 2025
Identifier
5R00CA267560-05
Award for research on radiation dosimetry and biological effects of alpha-particle radiopharmaceutical therapy targeting pediatric neuroblastoma, involving microdosimetry, DNA damage modeling, and biodistribution studies.
Description
This project aims to contribute to the precise determination of radiation dosimetry and biological effects of alpha particles in radiopharmaceutical treatments, particularly targeting pediatric neuroblastoma using [211At]MM4. It involves microdosimetric calculations, DNA damage modeling, and biodistribution studies to optimize alpha-particle radiotherapy.